Insights from 2023 ASCO® Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2023 ASCO® Annual Meeting

Breast
Hematology
Lung
GI
GU
GYN
Skin
Head and Neck
Sarcoma
CNS
Basic Science

Playback speed

10 seconds

ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Term Outcome of EV + Pembro in 1L Cisplatin-Ineligible Stage 3/4 UC With Nearly 4 Years of Follow-Up"

By Insights from 2023 ASCO® Annual Meeting FEATURING Shilpa Gupta

215 views

June 8, 2023

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

Assessment and Decision Tools for Balancing Survival and Quality of …

Insights from 2023 ASCO® Annual Meeting

E. Kessler

94 views

Concurrent Chemo-Hormonal Therapy of Enzalutamide and Cabazitaxel in…

Insights from 2023 ASCO® Annual Meeting

J. Graff, A. Sokolova

341 views

ASCO® 2023 Insights: "A Prospective Trial of Apalutamide & Abiratero…

Insights from 2023 ASCO® Annual Meeting

D. George

261 views

ASCO® 2023 Insights: "Determinants of Resistance to Nivo Monotherapy…

Insights from 2023 ASCO® Annual Meeting

D. Braun

70 views

ASCO® 2023 Insights: "Combination Therapies Come of Age in Kidney Ca…

Insights from 2023 ASCO® Annual Meeting

D. Braun

50 views

ASCO® 2023 Insights: "HR-QoL Measures in RCC - Patient-Reported Rele…

Insights from 2023 ASCO® Annual Meeting

C. Decat Bergerot

31 views

ASCO® 2023 Insights: "Discussion of LBA4619, Phase 3 THOR Study - Re…

Insights from 2023 ASCO® Annual Meeting

D. Petrylak

89 views

ASCO® 2023 Insights: "2L High-Dose Chemotherapy in Refractory/Recurr…

Insights from 2023 ASCO® Annual Meeting

E. Waller

113 views

ASCO® 2023 Insights: "Final Prespecified OS Analysis of CLEAR - 4-Ye…

Insights from 2023 ASCO® Annual Meeting

T. Hutson

300 views

ASCO® 2023 Insights: "When to Play the Systemic Therapy Card in Olig…

Insights from 2023 ASCO® Annual Meeting

K. Runcie

145 views

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients With…

Insights from 2023 ASCO® Annual Meeting

B. McGregor

454 views

ASCO® 2023 Insights: "Updated Analysis of Real-World Treatment Outco…

Insights from 2023 ASCO® Annual Meeting

Y. Zakharia

145 views

ASCO® 2023 Insights: "Use of ctDNA to Complement Tumor Tissue HRR Ge…

Insights from 2023 ASCO® Annual Meeting

A. Azad

36 views

ASCO® 2023 Insights: "Safety Analyses From the Randomized, Placebo-C…

Insights from 2023 ASCO® Annual Meeting

A. Azad

223 views

ASCO® 2023 Summary: "Key Bladder Cancer/Urothelial Carcinoma Updates"

Insights from 2023 ASCO® Annual Meeting

G. Sonpavde

376 views

ASCO® 2023 Insights: "PSMA-PET Imaging Case Studies and Sequencing D…

Insights from 2023 ASCO® Annual Meeting

P. Tran

630 views

ASCO® 2023 Insights: "Results of Phase 3 PEACE-1 Randomized Trial Wi…

Insights from 2023 ASCO® Annual Meeting

A. Bossi

56 views

ASCO® 2023 Insights: "Effect of CBM588 in Combination With Cabozanti…

Insights from 2023 ASCO® Annual Meeting

H. Ebrahimi

105 views

ASCO® 2023 Insights: "Association of Host Immune Signatures With Res…

Insights from 2023 ASCO® Annual Meeting

E. Saad

89 views

ASCO® 2023 Insights: "Updated Results for Cohort H of EV-103 Trial -…

Insights from 2023 ASCO® Annual Meeting

T. Flaig

111 views

ASCO® 2023 Poster Sessions From Dr. Andrew Armstrong in Prostate Can…

Insights from 2023 ASCO® Annual Meeting

A. Armstrong

523 views

ASCO® 2023 Insights: "Development & Validation of an AI-Derived Digi…

Insights from 2023 ASCO® Annual Meeting

A. Armstrong

61 views

ASCO® 2023 Insights: "Long-Term Safety of Avelumab 1L Maintenance fo…

Insights from 2023 ASCO® Annual Meeting

J. Bellmunt

84 views

ASCO® 2023 Insights: "Preliminary Results of Arm B5 of the Phase 1/2…

Insights from 2023 ASCO® Annual Meeting

L. Albiges

98 views

ASCO® 2023 Insights: "Adding Clarity to Non-Clear Cell Carcinoma"

Insights from 2023 ASCO® Annual Meeting

M. Schmidinger

295 views

ASCO® 2023 Insights: "Enfortumab Vedotin +/- Pembro in Pts Who Are C…

Insights from 2023 ASCO® Annual Meeting

T. Friedlander

235 views

ASCO® 2023 Insights: "Analysis of Pt-Level Data From SWOG-1216 Phase…

Insights from 2023 ASCO® Annual Meeting

N. Sayegh

80 views

ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Term Ou…

Insights from 2023 ASCO® Annual Meeting

S. Gupta

215 views

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

1.8K views

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Ad…

Insights from 2023 ASCO® Annual Meeting

B. McGregor

700 views

ASCO® 2023 Insights: "Efficacy and Safety Analysis of Sacituzumab Go…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

165 views

ASCO® 2023 Insights: "Phase I Dose-Escalation Results of PSMA-TRT Wi…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

165 views

ASCO® 2023 Insights: "FGFR3 Alterations in Phase III PROOF 302 Trial…

Insights from 2023 ASCO® Annual Meeting

P. Grivas

181 views

ASCO® 2023 Insights: "Phase 1b/2 Study of Batiraxcept (AVB-S6-500) a…

Insights from 2023 ASCO® Annual Meeting

K. Beckermann

130 views